The Value of Diagnostic Whole-Body Scanning and Serum Thyroglobulin in the Presence of Elevated Serum Thyrotropin During Follow-Up of Anti-Thyroglobulin Antibody–Positive Patients with Differentiated Thyroid Carcinoma Who Appeared to Be Free of Disease After Total Thyroidectomy and Radioactive Iodine Ablation
- 1 February 2012
- journal article
- research article
- Published by SAGE Publications in Thyroid®
- Vol. 22 (2) , 113-116
Abstract
Background: In the presence of anti-thyroglobulin antibodies (TgAb), serum thyroglobulin (Tg) might be underestimated. Therefore, the American Thyroid Association does not recommend serum Tg after thyroid hormone withdrawal or recombinant human thyrotropin administration (stimulated Tg) and diagnostic whole-body scanning (DxWBS) in TgAb-positive patients who have serum Tg values while on thyroxine (Tg-on-T4) of Methods: There were 121 women and 15 men in the study. By selection criteria, all of them had total thyroidectomy with apparent complete tumor resection, remnant ablation with 131I (1.1–5.5 GBq), and a post–131I therapy WBS that were negative for ectopic 131I uptake. On assessment 8–12 months after 131I ablation, their clinical exam needed to be normal, their Tg-on-T4 needed to be 1 ng/mL without disease on US and DxWBS were evaluated by other imaging methods. Results: In 10 (7.3%) patients, stimulated Tg was >1 ng/mL. The DxWBS revealed metastases in two of these patients, and other imaging methods showed disease in three others. Stimulated Tg was 1 ng/mL led to detection of persistent disease by other imaging methods in two more patients. Conclusions: Performing stimulated Tg and DxWBS at the same time seems to be useful after initial therapy in DTC patients with TgAb who do not otherwise appear to have persistent disease, even when US is negative.Keywords
This publication has 21 references indexed in Scilit:
- Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid CancerThyroid®, 2009
- Recommendations of the Latin American Thyroid Society on diagnosis and management of differentiated thyroid cancerArchives of Endocrinology and Metabolism, 2009
- Management of low-risk patients with thyroid carcinoma and detectable thyroglobulin on T4 after thyroidectomy and ablation with iodine-131Archives of Endocrinology and Metabolism, 2007
- Seguimento de pacientes de alto risco com carcinoma diferenciado de tireóide sem doença persistente após a terapia inicialArchives of Endocrinology and Metabolism, 2006
- European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epitheliumEuropean Journal of Endocrinology, 2006
- Is stimulation of thyroglobulin (Tg) useful in low-risk patients with thyroid carcinoma and undetectable Tg on thyroxin and negative neck ultrasound?Clinical Endocrinology, 2005
- Recombinant Human Thyrotropin-Stimulated Serum Thyroglobulin Combined with Neck Ultrasonography Has the Highest Sensitivity in Monitoring Differentiated Thyroid CarcinomaThe Journal of Clinical Endocrinology & Metabolism, 2003
- A Consensus Report of the Role of Serum Thyroglobulin as a Monitoring Method for Low-Risk Patients with Papillary Thyroid CarcinomaThe Journal of Clinical Endocrinology & Metabolism, 2003
- Is the Serum Thyroglobulin Response to Recombinant Human Thyrotropin Sufficient, by Itself, to Monitor for Residual Thyroid Carcinoma?The Journal of Clinical Endocrinology & Metabolism, 2002
- Is Diagnostic Iodine-131 Scanning Useful after Total Thyroid Ablation for Differentiated Thyroid Cancer?The Journal of Clinical Endocrinology & Metabolism, 2000